1. Na JY, Park JP, Park HJ, et al. The statistical analysis on legal autopsy performed in Korea during 2012 year. Korean J Leg Med. 2013; 37:198–207.
Article
2. Saukko P, Knight B. Knight's forensic pathology. 3rd ed.London: Arnold;2004. p. 495–502.
3. Laird DW. Life cycle of connexins in health and disease. Biochem J. 2006; 394:527–43.
Article
4. Beardslee MA, Lerner DL, Tadros PN, et al. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res. 2000; 87:656–62.
Article
5. Turner MS, Haywood GA, Andreka P, et al. Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels. Circ Res. 2004; 95:726–33.
Article
6. Hatanaka K, Kawata H, Toyofuku T, et al. Down-regulation of connexin43 in early myocardial ischemia and protective effect by ischemic preconditioning in rat hearts in vivo. Jpn Heart J. 2004; 45:1007–19.
Article
7. Matsushita S, Kurihara H, Watanabe M, et al. Alterations of phosphorylation state of connexin 43 during hypoxia and reoxygenation are associated with cardiac function. J Histochem Cytochem. 2006; 54:343–53.
Article
8. Ortmann C, Pfeiffer H, Brinkmann B. A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med. 2000; 113:215–20.
Article
9. Campobasso CP, Dell'Erba AS, Addante A, et al. Sudden cardiac death and myocardial ischemia indicators: a comparative study of four immunohistochemical markers. Am J Forensic Med Pathol. 2008; 29:154–61.
10. Kawamoto O, Michiue T, Ishikawa T, et al. Immunohistochemistry of connexin43 and zonula occludens-1 in the myocardium as markers of early ischemia in autopsy material. Histol Histopathol. 2014; 29:767–75.